F19.232
Other psychoactive substance dependence with withdrawal with perceptual disturbance
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F19.232 pertains to a specific type of substance dependence involving psychoactive substances. This condition is characterized by dependence on various psychoactive drugs, accompanied by withdrawal symptoms and perceptual disturbances. Often associated with substances like opioids, stimulants, or hallucinogens, this diagnosis highlights the complex nature of substance use disorders and their effects on mental health. Recognizing the features of this condition is important for those seeking appropriate treatment and support.
Causes & Symptoms
Clinical Causes: Repeated use of psychoactive substances such as opioids, stimulants, or hallucinogens Psychological dependence due to emotional or environmental factors Genetic predisposition influencing susceptibility to addiction Environmental influences including peer pressure, stress, and availability of substances Use of substances during vulnerable periods, such as adolescence or stressful life events
Key Symptoms: Craving or strong desire to use the substance Inability to control or reduce substance intake despite wishing to do so Development of tolerance, requiring higher doses over time to achieve the same effect Withdrawal symptoms when not using the substance, such as sweating, agitation, or nausea Perceptual disturbances, including hallucinations or altered perceptions of reality Mood swings, anxiety, or paranoia related to substance use or withdrawal Neglect of responsibilities or personal health in favor of substance use Physical symptoms like tremors, dizziness, or heart issues during withdrawal
Diagnostic & Treatment
Diagnosis Path: The diagnosis involves a comprehensive assessment by healthcare professionals, including detailed patient history, physical examination, and possibly psychological evaluations. Criteria include evidence of dependence, withdrawal symptoms, and perceptual disturbances associated with substance use. Laboratory tests or toxicology screens may be used to confirm substance involvement. It's essential to distinguish this condition from other mental health or medical issues that might mimic similar symptoms.
Treatment Protocols: Detoxification or medically supervised withdrawal to manage symptoms safely Psychological therapies such as cognitive-behavioral therapy (CBT) or motivational interviewing Medication-assisted treatment (MAT) when appropriate, using drugs to reduce cravings or manage withdrawal symptoms Support groups and counseling to address underlying psychological or environmental factors Relapse prevention strategies to maintain long-term sobriety Addressing co-occurring mental health disorders, like anxiety or depression
Clinical Advice & FAQs
Billing Guidance
Is F19.232 a billable ICD-10 code?
Yes, F19.232 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.232?
Clinical documentation must specify the nature of Other psychoactive substance dependence with withdrawal with perceptual disturbance and any associated comorbidities for accurate reporting.
Cite this Clinical Reference